AI scribes and startup incubators are transforming the evaluation process of AI technologies in healthcare and tech investments. The focus is on balancing innovation with ethical considerations like patient consent and strategic startup growth. The evolving landscape requires health systems and investors to adapt to new evaluation criteria.
